How An Alzheimer Treatment ' s Success Highlights The Failures In Alzheimer ' s Drug Research

How the takeover of a biotech company with a late stage Alzheimer ' s Drug highlights the lack of any other success in the fight against Alzheimer ' s. And how we must look at new ways to advance research in Alzheimer ' s if we want to break the bleak pattern of failure.

Source: Forbes.com Healthcare News - October 12, 2018 Category: Pharmaceuticals Authors: Steve Brozak, Contributor Tags: LLY:NYSE AXON:NASDAQ GSK:NYSE CORI:NASDAQ Source Type: news